🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

RecruitingNAAges 40 Years - 85 YearsAllTel-Aviv Sourasky Medical Center
NCT07380737 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria); * Hoehn \& Yahr stage II-III (ON-medication state); * Able to walk independently for ≥5 minutes; * Stable medication for ≥1 month; * Currently enrolled in a rehab program at Ezra LeMarpe; * Able to provide written informed consent; Exclusion Criteria: * Musculoskeletal, neurological, or visual/hearing impairments affecting gait; * Cognitive impairments or severe behavioral symptoms; * History of stroke, severe TBI, or brain tumor; * Cardiovascular contraindications; * Inability to use a smartphone; * Participation in other concurrent intervention studies.
💊

What it tests

  • Walking Tall App
📍

Where

1 site
Tel Aviv Sourasky Medical Center (Ichilov Hospital)
Tel Aviv, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy